Published in Cardiovasc Diabetol on July 11, 2012
Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACCORD) | NCT00000620
A comparison of four different approaches to measuring health utility in depressed patients. Health Qual Life Outcomes (2013) 0.87
Patient and societal value functions for the testing morbidities index. Med Decis Making (2013) 0.84
Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index. Med Decis Making (2015) 0.76
Negative effects of diabetes-related distress on health-related quality of life: an evaluation among the adult patients with type 2 diabetes mellitus in three primary healthcare clinics in Malaysia. Health Qual Life Outcomes (2015) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol (2007) 9.62
Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ (1998) 8.27
The estimation of a preference-based measure of health from the SF-12. Med Care (2004) 7.25
Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics (1995) 4.03
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making (2002) 2.96
Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making (2001) 2.49
Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Econ (2006) 2.08
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (2005) 2.07
The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. Int J Obes (Lond) (2006) 1.93
Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. Int J Technol Assess Health Care (2006) 1.91
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol (2007) 1.85
The minimally clinically important difference in generic utility-based measures. COPD (2005) 1.56
Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics (2000) 1.51
Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health (2001) 1.51
Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. Cardiovasc Diabetol (2011) 1.45
Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res (2007) 1.39
The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care (2006) 1.38
Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ (2005) 1.35
Changes in health state utilities with changes in body mass in the Diabetes Prevention Program. Obesity (Silver Spring) (2009) 1.24
Visual analog scales, standard gambles, and relative risk aversion. Med Decis Making (2001) 1.24
Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes (2007) 1.22
An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. Eur J Health Econ (2007) 1.18
Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ (2005) 1.16
Comparing utility scores before and after hearing-aid provision : results according to the EQ-5D, HUI3 and SF-6D. Appl Health Econ Health Policy (2004) 1.11
A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ (2003) 1.10
Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? Health Qual Life Outcomes (2005) 1.09
The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health (2008) 1.08
Assessing differences in utility scores: a comparison of four widely used preference-based instruments. Value Health (2007) 1.06
Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients. Qual Life Res (2004) 1.06
Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States. Cardiovasc Diabetol (2010) 1.02
Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes. J Clin Epidemiol (2006) 1.01
Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis Rheum (2007) 1.00
Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health (2004) 0.96
Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007. Prev Chronic Dis (2010) 0.94
Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. Am J Cardiol (2007) 0.94
A clinical trial to evaluate the measurement properties of 2 direct preference instruments administered with and without hypothetical marker states. Med Decis Making (2003) 0.93
Valuing health for clinical and economic decisions: directions relevant for rheumatologists. J Rheumatol (2011) 0.91
Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Qual Life Res (2011) 0.91
Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients. Health Qual Life Outcomes (2006) 0.90
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Diabet Med (2007) 0.90
Evaluation and measurement of health-related quality of life for individuals with diabetes mellitus by Health Utilities Index Mark 3 (HUI3) system. ScientificWorldJournal (2006) 0.89
A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease. Med Care (2004) 0.88
A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making (2003) 0.87
Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort. Diabet Med (2012) 0.85
Use of visual analog scales in economic evaluation. Expert Rev Pharmacoecon Outcomes Res (2003) 0.82
Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes. Med Decis Making (2011) 0.79
Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006. Cardiovasc Diabetol (2011) 0.77
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol (2007) 9.62
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet (2008) 9.03
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med (2011) 8.14
Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med (2006) 7.32
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension (2008) 6.96
Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med (2004) 6.77
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med (2005) 6.63
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58
The evolving diabetes burden in the United States. Ann Intern Med (2004) 6.36
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA (2012) 6.29
Incidence of childhood obesity in the United States. N Engl J Med (2014) 6.07
A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med (2002) 5.64
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.78
Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med (2010) 4.73
Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med (2007) 4.64
Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care (2003) 4.22
Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med (2006) 4.17
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care (2010) 4.10
Relationship of walking to mortality among US adults with diabetes. Arch Intern Med (2003) 3.95
De facto long-term opioid therapy for noncancer pain. Clin J Pain (2008) 3.85
Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care (2006) 3.67
Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation (2005) 3.61
Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA (2013) 3.55
Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol (2007) 3.54
The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med (2010) 3.42
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med (2008) 3.33
Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: experience in 4 US communities from 1987-2000. Am Heart J (2005) 3.32
Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf (2009) 3.25
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol (2012) 3.11
Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med (2008) 3.11
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2007) 3.08
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg (2013) 3.06
Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation (2012) 2.99
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics (2005) 2.85
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med (2011) 2.82
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82
Associations between recent exposure to ambient fine particulate matter and blood pressure in the Multi-ethnic Study of Atherosclerosis (MESA). Environ Health Perspect (2008) 2.80
Structural insights into the regulatory particle of the proteasome from Methanocaldococcus jannaschii. Mol Cell (2009) 2.75
Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle (2010) 2.64
Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med (2015) 2.64
Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. Am J Prev Med (2004) 2.62
What does it mean to call chronic pain a brain disease? J Pain (2013) 2.54
Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain (2010) 2.54
Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care (2010) 2.49
A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci (2003) 2.47
Improving Diabetes Care in Practice: findings from the TRANSLATE trial. Diabetes Care (2008) 2.42
Aging, retirement, and changes in physical activity: prospective cohort findings from the GLOBE study. Am J Epidemiol (2007) 2.36
Intensity of Chronic Pain--The Wrong Metric? N Engl J Med (2015) 2.34
Opioid Dependence vs Addiction: A Distinction Without a Difference? Arch Intern Med (2012) 2.33
Health of foreign-born people in the United States: a review. Health Place (2008) 2.29
Considerations for diabetes translational research in real-world settings. Diabetes Care (2003) 2.26
Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care (2002) 2.24
Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation (2007) 2.22
One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project. Diabetes Care (2011) 2.21
Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care (2007) 2.20
Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J Gen Intern Med (2014) 2.20
Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension (2007) 2.20
Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med (2012) 2.19
Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual (2006) 2.19
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol (2004) 2.18
Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol (2011) 2.16
Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care (2007) 2.16
Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis (2007) 2.15
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol (2008) 2.14
Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health (2010) 2.13
Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J (2006) 2.10
Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain (2009) 2.09
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation (2005) 2.08
Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08
Collaborative care for chronic pain in primary care: a cluster randomized trial. JAMA (2009) 2.07
Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care (2008) 2.07
Key issues in transforming health care organizations for quality: the case of advanced access. Jt Comm J Qual Saf (2004) 2.05
Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med (2008) 2.04
Functional implications of the localization and activity of acid-sensitive channels in rat peripheral nervous system. Proc Natl Acad Sci U S A (2002) 2.04